CSLLY:OTCMKTS
CSL ADR
$34.76
arrow_downward
-0.57%(-0.20) 1D
Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSLLY...
Open
$36.06
High
$36.06
Low
$33.36
Mkt. cap
96.35B
Avg. vol.
55.57K
Volume
54.74K
52-wk high
$36.88
52-wk low
$16.01
Beta
0.50
Shares outstanding
1.92B
No. of employees
29K
Open
$36.06
High
$36.06
Low
$33.36
Mkt. cap
96.35B
Avg. vol.
55.57K
Volume
54.74K
52-wk high
$36.88
52-wk low
$16.01
Beta
0.50
Shares outstanding
1.92B
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
3 days ago
Do I still rate CSL shares as a buy after rising 120% in four months?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorHealth Care
IndustryBiotechnology
Websitecsl.com